Fosun-backed automotive services provider CassTime has now raised approximately $260m altogether, Source Code Capital having led its series C3 round.

CR Pharma was among the investors in a $45.8m round that pushed the gene therapy developer's funding to about $170m in the past 14 months.

The Didi and Daimler-backed ride hailing service was reportedly valued in excess of $4bn in a round led by D1 Capital Partners.

Eli Lilly and Jointown-backed Singlera Genomics will put the series B financing into advancing its pipeline of cancer screening products.

UCB Ventures and GV returned for the neurodegenerative, neuromuscular and retinal disease drug developer's series B round.

Seek will take a board seat at HR and employee management platform developer Hibob having co-led a round that pushed its total funding to $124m.

Drug release technology developer Rani has now raised $211m in all, from investors including GV, Novartis, Ping An Ventures, KPC, AstraZeneca and Stevanato.

Sony Innovation Fund and Verizon Ventures came onboard as the drone avoidance system developer closed its series B round.

The energy-processing technology provider has raised $12.5m in a round led by newly minted strategic partner Synaptics.

Kissei Pharmaceutical has become the cancer immunotherapy developer's first corporate investor, in a series D round bringing its overall funding to $93.5m.